BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23994632)

  • 1. Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer.
    Xiao W; Wang J; Ou C; Zhang Y; Ma L; Weng W; Pan Q; Sun F
    Biochem Biophys Res Commun; 2013 Sep; 439(2):167-72. PubMed ID: 23994632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
    Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
    Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer.
    Li L; Wang J; Zhang Y; Zhang Y; Ma L; Weng W; Qiao Y; Xiao W; Wang H; Yu W; Pan Q; He Y; Sun F
    FEBS Lett; 2013 Dec; 587(24):3921-7. PubMed ID: 24211253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
    Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
    Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.
    Ma L; Wang J; Lin J; Pan Q; Yu Y; Sun F
    J Biol Chem; 2014 Mar; 289(10):6921-6933. PubMed ID: 24482231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP activation is an early event and a potential therapeutic target in liver cancer development.
    Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A
    J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
    Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
    Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional integration of mitogenic and mechanical signals by Myc and YAP.
    Croci O; De Fazio S; Biagioni F; Donato E; Caganova M; Curti L; Doni M; Sberna S; Aldeghi D; Biancotto C; Verrecchia A; Olivero D; Amati B; Campaner S
    Genes Dev; 2017 Oct; 31(20):2017-2022. PubMed ID: 29141911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease.
    Cai J; Song X; Wang W; Watnick T; Pei Y; Qian F; Pan D
    Genes Dev; 2018 Jun; 32(11-12):781-793. PubMed ID: 29891559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo.
    Kim MK; Park JY; Kang YN
    Pathol Res Pract; 2018 Jul; 214(7):1031-1039. PubMed ID: 29699904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
    Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.
    Lei L; Wu J; Gu D; Liu H; Wang S
    Tumour Biol; 2016 Aug; 37(8):11073-9. PubMed ID: 26906552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
    Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
    Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUAK2 is a critical YAP target in liver cancer.
    Yuan WC; Pepe-Mooney B; Galli GG; Dill MT; Huang HT; Hao M; Wang Y; Liang H; Calogero RA; Camargo FD
    Nat Commun; 2018 Nov; 9(1):4834. PubMed ID: 30446657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
    Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
    Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.